NIH-funded research R21 grant

Understanding how Veillonella bacteria produce heme to inhibit harmful bacteria in the mouth

Official title: Hemin Production by Veillonella: A Novel Mechanism in Inhibiting P. gingivalis Hemolysis

Funded at University of Texas Hlth Sci Ctr Houston · NIH-10952111 · Data updated 2026-11-12

This study is looking at how a friendly bacteria called Veillonella, found in your mouth, helps produce a nutrient that could protect against a harmful bacteria linked to gum disease, and it aims to find out how this could improve oral health and prevent problems.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 18, 2024
Project endSeptember 17, 2026
Funding year2024
Award (this year)$429,000
NIH project number1R21DE034098-01
Project IDNIH-10952111 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from periodontal disease or those at risk of developing it due to bacterial imbalances in the oral cavity.

Less likely to help

Patients who do not have periodontal disease or related oral health issues may not benefit from this research.

What this research studies

This research investigates the role of Veillonella, a type of bacteria found in dental plaque, in producing heme, a vital nutrient for other bacteria like Porphyromonas gingivalis, which is linked to periodontal disease. The study aims to understand how Veillonella's heme production can inhibit the harmful effects of P. gingivalis, particularly its ability to break down red blood cells and cause inflammation. By using advanced techniques such as RNA sequencing and protease assays, researchers will explore the mechanisms behind this interaction, potentially revealing new insights into oral health and disease prevention.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating periodontal disease by targeting bacterial interactions in the mouth.

How similar studies have gone: While the specific approach of targeting Veillonella's heme production is novel, similar studies have shown promise in understanding bacterial interactions in oral health.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Zhou, Peng — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Zhou, Peng

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.